Skip to main content

#151441

Anti-Keratin14 [LL002]

Cat. #151441

Anti-Keratin14 [LL002]

Cat. #: 151441

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Keratin 14

Class: Monoclonal

Application: FACS ; IHC ; IF ; WB

Reactivity: Human ; Mouse ; Pig

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Birgit Lane

Institute: Queen Mary University of London

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Keratin14 [LL002]
  • Research fields: Cell signaling and signal transduction
  • Clone: LL002
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 50 kDa
  • Strain: Balb/c
  • Reactivity: Human ; Mouse ; Pig
  • Host: Mouse
  • Application: FACS ; IHC ; IF ; WB
  • Description: Monoclonal antibody directed keratin 14, with use in identifying squamous cell carcinoma, and distinguishing basal breast carcinomas.
  • Immunogen: The last 16 carboxy-terminal amino acids of human keratin, in the form of a synthetic peptide. This was coupled to thyroglobulin by the extra Cys added at the N terminus.
  • Immunogen uniprot id: P02533
  • Isotype: IgG3
  • Myeloma used: Sp2/0-Ag14

Target Details

  • Target: Keratin 14
  • Molecular weight: 50 kDa
  • Target background: Monoclonal antibody directed keratin 14, with use in identifying squamous cell carcinoma, and distinguishing basal breast carcinomas.

Applications

  • Application: FACS ; IHC ; IF ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: Store at -20° C frozen. Avoid repeated freeze / thaw cycles
  • Shipping conditions: Dry ice

References

  • Hagiyama et al. 2017. Front Physiol. 8:997. PMID: 29259558.
  • Kuga et al. 2016. Sci Rep. 6:26557. PMID: 27222304.
  • Haikala et al. 2016. Cell Cycle. 15(3):316-23. PMID: 26873145.
  • Bohn et al. 2010. Int J Clin Exp Pathol. 3(6):600-7. PMID: 20661408.
  • p16INK4a expression in basal-like breast carcinoma.
  • Kurzrock et al. 2008. Am J Physiol Renal Physiol. 294(6):F1415-21. PMID: 18367656.
  • Label-retaining cells of the bladder: candidate urothelial stem cells.
  • Purkis et al. 1990. J Cell Sci. 97 ( Pt 1):39-50. PMID: 1701769.
  • Antibody markers of basal cells in complex epithelia.
  • Schaafsma et al. 1990. Am J Pathol. 136(2):329-43. PMID: 1689541.
  • Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.